After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Bioventus Inc is $814.79M. A total of 0.37 million shares were traded on the day, compared to an average of 377.93K shares.
In the most recent transaction, Claypoole Robert E sold 28,786 shares of BVS for 9.10 per share on Jan 13 ’25. After the transaction, the President and CEO now owns 64,964 company shares. In a previous transaction on Jan 13 ’25, Claypoole Robert E bought 33,000 shares at 9.55 per share.
Among the insiders who sold shares, Singleton Mark Leonard disposed of 10,733 shares on Dec 23 ’24 at a per-share price of $10.53. This resulted in the SVP & CFO holding 105,162 shares of BVS after the transaction. In another insider transaction, CHURCH KATRINA J sold 2,535 shares at $10.53 per share on Dec 23 ’24. Company shares held by the SVP & Chief Compliance Officer now total 47,264.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BVS has a high of $14.38 and a low of $3.90.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BVS’s latest balance sheet shows that the firm has $43.93M in Cash & Short Term Investments as of fiscal 2021. There were $357.68M in debt and $180.86M in liabilities at the time. Its Book Value Per Share was $2.28, while its Total Shareholder’s Equity was $533.79M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BVS is Buy with a score of 4.33.
